Te. Madden et Sw. Johnson, GAMMA-HYDROXYBUTYRATE IS A GABA(B) RECEPTOR AGONIST THAT INCREASES A POTASSIUM CONDUCTANCE IN RAT VENTRAL TEGMENTAL DOPAMINE NEURONS, The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 261-265
gamma-Hydroxybutyric acid (GHB) is an abused substance that occurs nat
urally in the basal ganglia. Electrophysiological recordings of membra
ne voltage and current were made to characterize the effects of GHB on
dopamine neurons in the ventral tegmental area of the rat midbrain sl
ice. Perfusate containing GHB caused a concentration-dependent membran
e hyperpolarization (EC50 = 0.88 +/- 0.21 mM) and a reduction in input
resistance (EC50 = 0.74 +/- 0.21 mM). The highest concentration of GH
B studied (10 mM) hyperpolarized neurons by 20 +/- 3 mV and reduced in
put resistance by 58% +/- 9%. Changes in membrane potential and input
resistance were blocked by the gamma-aminobutyric acid antagonist CGP-
35348 (300 mu M), but neither bicuculline (30 mu M) nor strychnine (10
mu M) was an effective antagonist. Voltage-clamp recordings demonstra
ted that GHB (1 mM) evoked 80 +/- 6 pA of outward current (at -60 mV)
that reversed at -110 mV (in 2.5 mM K+). Increasing concentrations of
extracellular K+ progressively shifted the reversal to more depolarize
d potentials. In tetrodotoxin (0.3 mu M) and tetraethylammonium (10 mM
), depolarizing voltage steps (to -30 mV) evoked calcium-dependent cur
rent spikes that were completely blocked by GHB (1 mM). These data sug
gest that GHB is an agonist at gamma-aminobutyric acid receptors and w
ould be expected to inhibit DA release by causing K+-dependent membran
e hyperpolarization.